Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

US Patent 9822367 · Granted Nov 21, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising SASP modulators and senescence attenuators and uses ther2024
Compositions and methods for treating and preventing inflammation2023
Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability2022
Method and system for delivering exogenous biomolecules into the eye and method 2021
Compositions and methods for treating and preventing inflammation2020
Compositions and methods for treating and preventing inflammation2020
Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability2020